Call for less regulation in German healthcare sector
This article was originally published in Clinica
Executive Summary
Germany's industry federation, the BDI, has urged that market forces be allowed to have due influence over the national healthcare products sector. Speaking at the annual general meeting of medtech industry association Spectaris, in Stuttgart last week, BDI deputy-president Friedhelm Loh said: "German can only be a worldwide leader in healthcare innovations when there is free pricing that promotes competition for such innovative products." He added that only then will it be possible for companies to invest in relatively costly and high-risk products.
You may also be interested in...
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.